Atlas Trials

Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL

Clinical trial NCT04342117 · TERMINATED

Trial details

NCT number
NCT04342117
Sponsor
SecuraBio
Status
TERMINATED
Study type
OBSERVATIONAL
Lymphoma, Small LymphocyticLymphomaLymphoma, Non-HodgkinChronic Lymphocytic LeukemiaFollicular Lymphoma
Start date
2020-04-23
Primary completion
2020-12-31
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.